About this trial
To evaluate the effects of probiotic intervention on gastrointestinal function in patients with constipation after 4 weeks of treatment, and to explore its potential effects on immune status and bone metabolism.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 18-65 years.
Patients with constipation, defined as fewer than three bowel movements per week and/or Bristol Stool Form Scale (BSFS) types 1-2.
Able to comply with the study protocol and complete the study procedures.
Participants who have voluntarily signed the informed consent form.
Disqualifiers
Individuals who have recently taken products with similar functions to the investigational product that may affect the evaluation of study outcomes.
Participants who plan to change their dietary habits during the study period.
Patients with severe allergies or immunodeficiency.
Women who are pregnant, breastfeeding, or planning to become pregnant.
Trial design
Parallel
Treatments tested in this trial
GUT99 1
Dietary supplementTaken orally once daily for 8 weeks (120B).
Placebo
Dietary supplementTaken orally once daily for 8 weeks.
GUT99 2
Dietary supplementTaken orally once daily for 8 weeks (1000B).
Treatment groups
Trial outcomes
Primary outcomes
Changes in stool consistency
Stool consistency will be evaluated using the Bristol Stool Form Scale (BSFS) to assess the improvement of constipation symptoms in patients receiving probiotic intervention.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: